Cancer Center Support Grant

$5,443,934P30FY2025CANIH

Columbia University Health Sciences, New York NY

Investigators

Linked publications & trials

Paper 39764007 Paper 39763754 Paper 39730789 Paper 39694413 Paper 39678350 Paper 39677801 Paper 39677717 Paper 39672986 Paper 39632839 Paper 39605351 Paper 39525274 Paper 39510068 Paper 39484519 Paper 39475605 Paper 39427044 Paper 39424708 Paper 39416157 Paper 39391900 Paper 39389809 Paper 39386571 Paper 39383878 Paper 39383220 Paper 39374382 Paper 39372929 Paper 39345403 Paper 39334892 Paper 39315275 Paper 39265081 Paper 39257805 Paper 39257765 Paper 39256571 Paper 39229162 Paper 39229152 Paper 39196936 Paper 39195859 Paper 39192032 Paper 39183190 Paper 39180940 Paper 39179580 Paper 39178842 Paper 39164253 Paper 39141382 Paper 39134708 Paper 39105568 Paper 39105287 Paper 39095358 Paper 39094066 Paper 39030196 Paper 39024216 Paper 39009816 Paper 39007497 Paper 38991829 Paper 38956205 Paper 38935497 Paper 38933266 Paper 38902234 Paper 38854018 Paper 38848678 Paper 38848342 Paper 38838145 Paper 38831614 Paper 38824644 Paper 38824526 Paper 38809096 Paper 38798673 Paper 38776397 Paper 38769293 Paper 38767413 Paper 38754428 Paper 38741711 Paper 38739694 Paper 38717153 Paper 38684185 Paper 38657601 Paper 38645164 Paper 38625984 Paper 38621575 Paper 38609522 Paper 38588697 Paper 38588334 Paper 38585856 Paper 38559188 Paper 38555449 Paper 38522750 Paper 38522021 Paper 38521544 Paper 38511265 Paper 38483541 Paper 38454137 Paper 38450935 Paper 38428422 Paper 38402864 Paper 38385291 Paper 38364947 Paper 38362011 Paper 38352515 Paper 38343836 Paper 38339887 Paper 38328122 Paper 38309273

Abstract

The Herbert Irving Comprehensive Cancer Center (HICCC) was designated as a National Cancer Institute (NCI) Cancer Center in 1972 and gained Comprehensive status in 1979.Â Under the Directorship of Anil K. Rustgi, MD, the HICCC is the critical driver of cancer research, clinical trials, innovative cancer care, cancer education and training, and community outreach at Columbia University Irving Medical Center (CUIMC) and NewYork-Presbyterian Hospital (NYPH). During the current project period (2020-2024), CUIMC and NYPH supported the following: (1) new research initiatives in basic, translational, clinical, and population sciences with >75 strategic faculty recruitments; (2) new and expanded facilities for laboratory research, dry bench research and clinical activities; and (3) support of the HICCCâs administrative core. Rustgi has the unequivocal authority over cancer research space and cancer care facilities, further reinforced through his dual roles as Associate Dean of Oncology (CUIMC) and Chief of Cancer Services (NYPH). Over this project period, there was a greater focus upon transdisciplinary cross-cutting scientific themes that catalyzed the restructuring of the four scientific Research Programs encompassing 203 Members from 32 Departments and six Schools: (1) Cancer Genomics and Epigenomics; (2) Tumor Biology and Microenvironment; (3) Precision Oncology and Systems Biology; and (4) Cancer Population Science. Importantly, the HICCC has vibrant offices dedicated to Community Outreach and Engagement (COE) and Cancer Research Training and Education Coordination Enhancement (CRTEC). Rustgi has also enhanced the eight Shared Resources. The Research Programs engendered impactful science with 1,912 cancer relevant research publications of which 24% were intra-programmatic and 15% were inter-programmatic. Total peer-reviewed research funding is $81.1M, of which $37.9M is from NCI and $31.2 is from other NIH agencies, and $11.6M is form other peer-reviewed organizations. Total cancer-relevant research funding is $123.6M. The HICCC is requesting CCSG support of $3,922,908 per year (direct costs) for the next project period and continued designation as âComprehensiveâ.

View original record on NIH RePORTER →